Search

Your search keyword '"Ribera, Jose´ M."' showing total 27 results
Start Over Author "Ribera, Jose´ M."
27 results on '"Ribera, Jose´ M."'

1. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

Author

Sanz, Miguel A., Montesinos, Pau, Rayón, Chelo, Holowiecka, Alexandra, de la Serna, Javier, Milone, Gustavo, de Lisa, Elena, Brunet, Salut, Rubio, Vicente, Ribera, José M., Rivas, Concha, Krsnik, Isabel, Bergua, Juan, González, José, Díaz-Mediavilla, Joaquín, Rojas, Rafael, Manso, Félix, Ossenkoppele, Gert, González, José D., and Lowenberg, Bob

Published
2010
Full Text
View/download PDF

2. El anciano con cardiopatía terminal

Author

Martínez-Sellés, Manuel, Teresa Vidán, María, López-Palop, Ramón, Rexach, Lourdes, Sánchez, Elisabet, Datino, Tomás, Cornide, María, Carrillo, Pilar, Ribera, José M., Díaz-Castro, Óscar, and Bañuelos, Camino

Published
2009
Full Text
View/download PDF

3. End-Stage Heart Disease in the Elderly

Author

Martínez-Sellés, Manuel, Teresa Vidán, María, López-Palop, Ramón, Rexach, Lourdes, Sánchez, Elisabet, Datino, Tomás, Cornide, María, Carrillo, Pilar, Ribera, José M., Díaz-Castro, Óscar, and Bañuelos, Camino

Published
2009
Full Text
View/download PDF

6. CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians

Author

Agundez, Jose A.G., Rodriguez, Inmaculada, Olivera, Manuela, Ladero, Jose Maria, Garcia, Maria A., Ribera, Jose M., and Benitez, Julio

Subjects
Genetic research -- Analysis -- Genetic aspects, Aging -- Genetic aspects -- Analysis, Longevity -- Genetic aspects -- Analysis, Health, Psychology and mental health, Seniors, Social sciences, Analysis, Genetic aspects
Abstract

Keywords: longevity, CYP2D6, CYP2E1, NAT2, cytochrome P450, acetylator, polymorphisms Introduction The ageing process is largely multifactorial and many of these factors are under genetic control. Cardiovascular consequences of atherosclerosis and [...]

Published
1997

7. Early T cell activation in elderly humans

Author

Serra, Jose A., Fernandez-Gutierrez, Benjamin, Hernandez-Garcia, Cesar, Vidan, Maite, Banares, Antonio, Ribera, Jose M., and Jover, Juan A.

Subjects
T cells -- Physiological aspects, Aging -- Physiological aspects, Cellular signal transduction -- Physiological aspects, Cell differentiation -- Physiological aspects, Immune response -- Regulation, Health, Psychology and mental health, Seniors, Social sciences, Physiological aspects
Abstract

Keywords: Elderly people, CD69, T lymphocytes. Introduction Immunosenescence is associated with a deterioration of both cellular and humoral immunity [1], and may contribute to the age-related increase in tumours and [...]

Published
1996

8. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups: Presented in part at the 41st meeting of the American Society of Hematology, New Orleans, LA, December 3-7, 1999.

Author

Sanz, Miguel A., Coco, Francesco Lo, Martı́n, Guillermo, Avvisati, Giuseppe, Rayón, Consuelo, Barbui, Tiziano, Dı́az-Mediavilla, Joaquı́n, Fioritoni, Giuseppe, González, José David, Liso, Vincenzo, Esteve, Jordi, Ferrara, Felicetto, Bolufer, Pascual, Bernasconi, Carlo, Gonzalez, Marcos, Rodeghiero, Francesco, Colomer, Dolors, Petti, Maria C., Ribera, José M., and Mandelli, Franco

Published
2000
Full Text
View/download PDF

9. A Modified AIDA Protocol With Anthracycline-Based Consolidation Results in High Antileukemic Efficacy and Reduced Toxicity in Newly Diagnosed PML/RAR∝-Positive Acute Promyelocytic Leukemia: Presented in part at the 40th meeting of the American Society of Hematology, Miami Beach, FL, December 4-8, 1998.

Author

Sanz, Miguel A., Martín, Guillermo, Rayón, Consuelo, Esteve, Jordi, González, Marcos, Díaz-Mediavilla, Joaquín, Bolufer, Pascual, Barragán, Eva, Terol, María J., González, José D., Colomer, Dolors, Chillón, Carmen, Rivas, Concha, Gómez, Teresa, Ribera, José M., Bornstein, Rafael, Román, José, Calasanz, María J., Arias, Jesus, Álvarez, Carmen, Ramos, Fernando, and Debén, Guillermo

Published
1999
Full Text
View/download PDF

10. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

Author

Forero-Castro, Maribel, Robledo, Cristina, Benito Sánchez, Rocío, Bodega-Mayor, Irene, Rapado, Inmaculada, Hernández Rivas, Jesús María, Abáigar, María, Quijada-Alamo, Miguel, Sánchez-Pina, José M, Sala-Valdés, Mónica, Araujo-Silva, Fernanda, Kohlmann, Alexander, Fuster, José Luis, Arefi, Maryam, Heras, Natalia de las, Riesco, Susana, Rodríguez, Juan-Nicolás, Hermosín, Lourdes, Ribera, Jordi, Camos Guijosa, Mireia, Ramírez, Manuel, Díaz de Heredia Rubio, Cristina, Barragán, Eva, Martínez, Joaquín, Ribera, Jose M., and Fernández-Ruiz, Elena

Subjects
JAK2, Next-generation sequencing (NGS), Mutation, TP53, Acute lymphoblastic leukemia
Abstract

[EN]Background: In B-cell precursor acute lymphoblastic leukaemia (B-ALL), the identification of additional genetic alterations associated with poor prognosis is still of importance. We determined the frequency and prognostic impact of somatic mutations in children and adult cases with B-ALL treated with Spanish PETHEMA and SEHOP protocols. Methods: Mutational status of hotspot regions of TP53, JAK2, PAX5, LEF1, CRLF2 and IL7R genes was determined by next-generation deep sequencing in 340 B-ALL patients (211 children and 129 adults). The associations between mutation status and clinicopathological features at the time of diagnosis, treatment outcome and survival were assessed. Univariate and multivariate survival analyses were performed to identify independent prognostic factors associated with overall survival (OS), event-free survival (EFS) and relapse rate (RR). Results: A mutation rate of 12.4% was identified. The frequency of adult mutations was higher (20.2% vs 7.6%, P=0.001). TP53 was the most frequently mutated gene (4.1%), followed by JAK2 (3.8%), CRLF2 (2.9%), PAX5 (2.4%), LEF1 (0.6%) and IL7R (0.3%). All mutations were observed in B-ALL without ETV6-RUNX1 (P=0.047) or BCR-ABL1 fusions (P, European Commision (EC). Funding FP7/SP1/HEALTH. Project Code: 306242

Published
2017

11. Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation.

Author

Rovó, Alicia, Kulasekararaj, Austin, Medinger, Michael, Chevallier, Patrice, Ribera, Jose M., Peffault de Latour, Regis, Knol, Cora, Iacobelli, Simona, Kanfer, Edward, Bruno, Benedetto, Maury, Sébastien, Quarello, Paola, Koh, Mickey B. C., Schouten, Harry, Blau, Igor W., Tichelli, André, Hill, Anita, Risitano, Antonio, Passweg, Jakob, and Marsh, Judith

Subjects
APLASTIC anemia, LYMPHOMAS, BONE marrow transplantation, ASSOCIATIONS, institutions, etc., CANCER treatment
Abstract

The article examines diseases characteristics as well as treating centre attitudes concerning the therapy and outcome of patients having aplastic anaemia and lymphoma. The evaluation was peformed by Severe Aplastic Anaemia Working Party of the European Society of Blood and Bone Marrow Transplantation.

Published
2019
Full Text
View/download PDF

12. Stem cell mobilization in HIV seropositive patients with lymphoma

Author

Re, Alessandro, Cattaneo, Chiara, Skert, Cristina, Balsalobre, Pascual, Michieli, Mariagrazia, Bower, Mark, Ferreri, Andres J. M., Hentrich, Marcus, Ribera, Jose M., Allione, Bernardino, Schommers, Philipp, Montoto, Silvia, Almici, Camillo, Ferremi, Pierino, Mazzucato, Mario, Gattillo, Salvatore, Casari, Salvatore, Spina, Michele, Diez-Martin, Jose L., Tirelli, Umberto, Rossi, Giuseppe, Re, Alessandro, Cattaneo, Chiara, Skert, Cristina, Balsalobre, Pascual, Michieli, Mariagrazia, Bower, Mark, Ferreri, Andres J. M., Hentrich, Marcus, Ribera, Jose M., Allione, Bernardino, Schommers, Philipp, Montoto, Silvia, Almici, Camillo, Ferremi, Pierino, Mazzucato, Mario, Gattillo, Salvatore, Casari, Salvatore, Spina, Michele, Diez-Martin, Jose L., Tirelli, Umberto, and Rossi, Giuseppe

Abstract

High-dose chemotherapy with autologous peripheral blood stem cell rescue has been reported as feasible and effective in HIV-associated lymphoma. Although a sufficient number of stem cells seems achievable in most patients, there are cases of stem cell harvest failure. The aim of this study was to describe the mobilization policies used in HIV-associated lymphoma, evaluate the failure rate and identify factors influencing mobilization results. We analyzed 155 patients who underwent attempted stem cell mobilization at 10 European centers from 2000-2012. One hundred and twenty patients had non-Hodgkin lymphoma and 35 Hodgkin lymphoma; 31% had complete remission, 57% chemosensitive disease, 10% refractory disease, 2% untested relapse. Patients were mobilized with chemotherapy + G-CSF (86%) or G-CSF alone (14%); 73% of patients collected >2 and 48% >5 x 10(6) CD34(+) cells/kg. Low CD4+ count and refractory disease were associated with mobilization failure. Low CD4(+) count, low platelet count and mobilization with G-CSF correlated with lower probability to achieve >5 x 10(6) CD34(+) cells/kg, whereas cyclophosphamide >= 3 g/m(2) + G-CSF predicted higher collections. Circulating CD34(+) cells and CD34/WBC ratio were strongly associated with collection result. HIV infection alone should not preclude an attempt to obtain stem cells in candidates for autologous transplant as the results are comparable to the HIV-negative population.

Published
2013

13. Comparable survival between HIV+ and HIV− non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation

Author

Díez-Martín, José L., Balsalobre, Pascual, Re, Alessandro, Michieli, Mariagrazia, Ribera, José M., Canals, Carmen, Conde, Eulogio, Rosselet, Anne, Gabriel, Ian, Varela, Rosario, Allione, Bernardino, Cwynarski, Kate, Genet, Philippe, Espigado, Ildefonso, Biron, Pierre, Schmitz, Norbert, Hunter, Anne E., Ferrant, Augustin, Guillerm, Gaelle, Hentrich, Mark, Jurado, Manuel, Fernández, Pascual, Serrano, David, Rossi, Giuseppe, and Sureda, Anna

Published
2009
Full Text
View/download PDF

14. The European LeukemiaNet : achievements and perspectives

Author

Hehlmann, Ruediger, Grimwade, David, Simonsson, Bengt, Apperley, Jane, Baccarani, Michele, Barbui, Tiziano, Barosi, Giovanni, Bassan, Renato, Bene, Marie C., Berger, Ute, Buechner, Thomas, Burnett, Alan, Cross, Nicolas C. P., de Witte, Theo J. M., Doehner, Hartmut, Dombret, Herve, Einsele, Hermann, Engelich, Georg, Foa, Robin, Fonatsch, Christa, Goekbuget, Nicola, Gluckman, Elaine, Gratwohl, Alois, Guilhot, Francois, Haferlach, Claudia, Haferlach, Thorsten, Hallek, Michael, Hasford, Joerg, Hochhaus, Andreas, Hoelzer, Dieter, Kiladjian, Jean-Jaques, Labar, Boris, Ljungman, Per, Mansmann, Ulrich, Niederwieser, Dietger, Ossenkoppele, Gert, Ribera, Jose M., Rieder, Harald, Serve, Hubert, Schrotz-King, Petra, Sanz, Miguel A., Saussele, Susanne, Hehlmann, Ruediger, Grimwade, David, Simonsson, Bengt, Apperley, Jane, Baccarani, Michele, Barbui, Tiziano, Barosi, Giovanni, Bassan, Renato, Bene, Marie C., Berger, Ute, Buechner, Thomas, Burnett, Alan, Cross, Nicolas C. P., de Witte, Theo J. M., Doehner, Hartmut, Dombret, Herve, Einsele, Hermann, Engelich, Georg, Foa, Robin, Fonatsch, Christa, Goekbuget, Nicola, Gluckman, Elaine, Gratwohl, Alois, Guilhot, Francois, Haferlach, Claudia, Haferlach, Thorsten, Hallek, Michael, Hasford, Joerg, Hochhaus, Andreas, Hoelzer, Dieter, Kiladjian, Jean-Jaques, Labar, Boris, Ljungman, Per, Mansmann, Ulrich, Niederwieser, Dietger, Ossenkoppele, Gert, Ribera, Jose M., Rieder, Harald, Serve, Hubert, Schrotz-King, Petra, Sanz, Miguel A., and Saussele, Susanne

Abstract

The only way to cure leukemia is by cooperative research. To optimize research, the European Leukemia Net integrates 105 national leukemia trial groups and networks, 105 interdisciplinary partner groups and about 1,000 leukemia specialists from 175 institutions. They care for tens of thousands of leukemia patients in 33 countries across Europe. Their ultimate goal is to cure leukemia. Since its inception in 2002, the European Leukemia Net has steadily expanded and has unified leukemia research across Europe. The European Leukemia Net grew from two major roots: 1) the German Competence Network on Acute and Chronic Leukemias; and 2) the collaboration of European Investigators on Chronic Myeloid Leukemia. The European Leukemia Net has improved leukemia research and management across Europe. Its concept has led to funding by the European Commission as a network of excellence. Other sources (European Science Foundation; European Leukemia Net-Foundation) will take over when the support of the European Commission ends.

Published
2011
Full Text
View/download PDF

15. Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment In Elderly Patients with De Novo Philadelphia Positive ALL (EWALL-PH-01): Kinetic of Response, Resistance and Prognostic Significance

Author

Rousselot, Philippe, primary, Cayuela, Jean Michel, additional, Hayette, Sandrine, additional, Récher, Christian, additional, Leguay, Thibaut, additional, Salanoubat, Celia, additional, Witz, Francis, additional, Alexis, Magda, additional, Hunault, Mathilde, additional, Janvier, Maud, additional, Agape, Philippe, additional, Berthou, Christian, additional, Jourdan, Eric, additional, Fernandes, José, additional, Sutton, Laurent, additional, Banos, Anne, additional, Reman, Oumedaly, additional, Lioure, Bruno, additional, Thomas, Xavier, additional, Ifrah, Norbert, additional, Gokbuget, Nicola, additional, Hoelzer, Dieter, additional, Delannoy, Andre, additional, Bassan, Renato, additional, Ribera, Jose M., additional, Giebel, Sebastian, additional, Dombret, Herve, additional, and Ottmann, Oliver G., additional

Published
2010
Full Text
View/download PDF

16. Peripheral Blood Stem Cell Mobilization In Hiv Positive Patients with Lymphoma Candidates to Autologous Transplantation: Predictive Factors Analysis for Failure or Suboptimal Stem Cell Collection

Author

Re, Alessandro, primary, Balsalobre, Pascual, additional, Michieli, Mariagrazia, additional, Ribera, Jose M., additional, Allione, Bernardino, additional, Almici, Camillo, additional, Ferremi, Pierino, additional, Mazzucato, Mario, additional, Cattaneo, Chiara, additional, Casari, Salvatore, additional, Spina, Michele, additional, Skert, Cristina, additional, Diez-Martin, Jose L., additional, Tirelli, Umberto, additional, and Rossi, Giuseppe, additional

Published
2010
Full Text
View/download PDF

17. Geriatric Hypertension

Author

Ribera, Jose M.

Subjects
Geriatric Hypertension (Book) -- Book reviews, Books -- Book reviews, Health, Psychology and mental health, Seniors, Sociology and social work
Published
1990

18. Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Results of the PETHEMA LPA2005 Trial Using All-Trans Retinoic Acid and Anthracycline with Cytarabine for High-Risk Patients

Author

Sanz, Miguel A., primary, Montesinos, Pau, primary, Holowiecka, Aleksandra, primary, Milone, Gustavo, primary, Rayon, Chelo, primary, de Lisa, Elena, primary, de la Serna, Javier, primary, Brunet, Salut, primary, Leon, Angel, primary, Krsnik, Isabel, primary, Rivas, Concha, primary, Ribera, Jose M., primary, Gonzalez, Jose, primary, Mediavilla, Joaquín Díaz-, primary, Bueno, Javier, primary, Gonzalez, Jose David, primary, Bergua, Juan, primary, and Gonzalez, Marcos, primary

Published
2008
Full Text
View/download PDF

19. Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival

Author

Valcárcel, David, primary, Martino, Rodrigo, additional, Caballero, Dolores, additional, Martin, Jesus, additional, Ferra, Christelle, additional, Nieto, Jose B., additional, Sampol, Antonia, additional, Bernal, M. Teresa, additional, Piñana, Jose L., additional, Vazquez, Lourdes, additional, Ribera, Jose M., additional, Besalduch, Joan, additional, Moraleda, Jose M., additional, Carrera, Dolores, additional, Brunet, M. Salut, additional, Perez-Simón, Jose A., additional, and Sierra, Jorge, additional

Published
2008
Full Text
View/download PDF

20. Does Highly Active Anti-Retroviral Therapy (HAART) Delay Myeloid Engraftment after Autologous Stem Cell Transplant (ASCT) in HIV Associated Lymphoma (HIV+Ly) Patients?.

Author

Diez-Martin, Jose L., primary, Carrion, Rafael, primary, Anguita, Javier, primary, Balsalobre, Pascual, primary, Miralles, Pilar, primary, Berenguer, Juan, primary, Buno, Ismael, primary, Gomez-Pineda, Alfonso, primary, Conde, Eulogio, primary, Varela, Rosario, primary, Ribera, Jose M., primary, Espigado, Ildefonso, primary, Escoda, Lourdes, primary, Loscertales, Javier, primary, and Serrano, David, primary

Published
2005
Full Text
View/download PDF

21. Autologous Stem Cell Transplantation after FLAG-IDA Chemotherapy for High-Risk Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemias Secondary to MDS (sAML) Does Not Improve Outcome: A PETHEMA Experience in 103 Patients.

Author

Sanz, Guillermo F., primary, Mena-Duran, Armando V., primary, Ribera, Jose M., primary, Bernal, Teresa, primary, Palomera, Luis, primary, del Cañizo, Maria C., primary, Tormo, Mar, primary, Sayas, Maria J., primary, García-Boyero, Raimundo, primary, de la Serna, Javier, primary, Pérez-Encinas, Manuel, primary, Pérez-Sánchez, Montserrat, primary, Arilla, María J., primary, Moneva, Juan J., primary, Amigo, Maria L., primary, Benlloch, Luis, primary, Batlle, Montserrat, primary, and Rayon, Consuelo, primary

Published
2005
Full Text
View/download PDF

23. Prognostic Value of Immunophenotyping of Multiple Myeloma: A Study on 685 Patients Uniformly Treated with High-Dose Therapy.

Author

Mateo, Gema, Montalban, Maria A., Vidriales, Maria-Belén, Lahuerta, Juan J., Mateos, Maria-Victoria, Gutiérrez, Norma C., Rosiñol, Laura, Montejano, Laura, López-Berges, Ma Consuelo, Bladé, Joan, Martínez, Rafael, de la Rubia, Javier, Diaz-Mediavilla, Joaquín, Sureda, Anna, Ribera, José M., Ojanguren, José M., de Arriba, Felipe, Palomera, Luis, Terol, Ma José, Gardella, Santiago, Orfao, Alberto, and Miguel, J.F. San

Published
2007
Full Text
View/download PDF

24. Recombinant α2-Interferon in the Treatment of B Chronic Lymphocytic Leukemia in Early Stages

Author

Rozman, Ciril, Montserrat, Emilio, Vinolas, Nuria, Urbano-lspizua, Alvaro, Ribera, Jose M., Gallart, Teresa, and Compernolle, Chris

Abstract

Ten previously untreated patients with early B cell chronic lymphocytic leukemia (B-CLL) (seven in Rai's stage 0, three in stage I) were given recombinant α2-interferon (α2IF) (2 x 106U/m2intramuscularly three times a week for a minimum of 14 weeks) to assess its effectiveness. All patients were evaluable for response to therapy and toxicity. No complete response was achieved. In all cases a definite, although transient reduction in the absolute number of peripheral blood lymphocytes was observed. In eight patients an increase in the absolute number of granulo- cytes was detected. None of the patients experienced severe hematologic toxicity. Fatigue, malaise, and fever were the more common side effects, but all patients were able to finish their treatment as planned. The results of this pilot study suggest that low doses of recombinant α2-IF have some activity in early and previously untreated B-CLL and that further studies of IF effectiveness in B-CLL seem warranted.

Published
1988
Full Text
View/download PDF

25. Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment In Elderly Patients with De NovoPhiladelphia Positive ALL (EWALL-PH-01): Kinetic of Response, Resistance and Prognostic Significance

Author

Rousselot, Philippe, Cayuela, Jean Michel, Hayette, Sandrine, Récher, Christian, Leguay, Thibaut, Salanoubat, Celia, Witz, Francis, Alexis, Magda, Hunault, Mathilde, Janvier, Maud, Agape, Philippe, Berthou, Christian, Jourdan, Eric, Fernandes, José, Sutton, Laurent, Banos, Anne, Reman, Oumedaly, Lioure, Bruno, Thomas, Xavier, Ifrah, Norbert, Gokbuget, Nicola, Hoelzer, Dieter, Delannoy, Andre, Bassan, Renato, Ribera, Jose M., Giebel, Sebastian, Dombret, Herve, and Ottmann, Oliver G.

Abstract

Abstract 172

Published
2010
Full Text
View/download PDF

26. Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Results of the PETHEMA LPA2005 Trial Using All-TransRetinoic Acid and Anthracycline with Cytarabine for High-Risk Patients

Author

Sanz, Miguel A., Montesinos, Pau, Holowiecka, Aleksandra, Milone, Gustavo, Rayon, Chelo, de Lisa, Elena, de la Serna, Javier, Brunet, Salut, Leon, Angel, Krsnik, Isabel, Rivas, Concha, Ribera, Jose M., Gonzalez, Jose, Mediavilla, Joaquín Díaz-, Bueno, Javier, Gonzalez, Jose David, Bergua, Juan, and Gonzalez, Marcos

Abstract

Background: A previous report of the PETHEMA Group (Sanz et al, Blood 2004) showed that a risk-adapted strategy combining ATRA and anthracycline monochemotherapy for induction and consolidation (LPA99 trial), followed by ATRA and low dose methotrexate and mercaptopurine for maintenance therapy, resulted in high antileukemic efficacy, moderate toxicity, and a high degree of compliance. A critical analysis of this study led us to consider the following opportunities for improvement in a new trial:

Published
2008
Full Text
View/download PDF

27. Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation

Author

Patrice Chevallier, Harry C. Schouten, Peter Dreger, Anita J. Hill, Judith C. W. Marsh, André Tichelli, Sébastien Maury, Antonio M. Risitano, Carlo Dufour, Régis Peffault de Latour, Simona Iacobelli, Michael Medinger, Benedetto Bruno, Edward Kanfer, Austin G. Kulasekararaj, Alicia Rovó, Mickey Koh, Igor Wolfgang Blau, Paola Quarello, Jose M Ribera, Cora Knol, Jakob Passweg, Rovó, Alicia, Kulasekararaj, Austin, Medinger, Michael, Chevallier, Patrice, Ribera, Jose M., Peffault de Latour, Regi, Knol, Cora, Iacobelli, Simona, Kanfer, Edward, Bruno, Benedetto, Maury, Sébastien, Quarello, Paola, Koh, Mickey B. C., Schouten, Harry, Blau, Igor W., Tichelli, André, Hill, Anita, Risitano, Antonio, Passweg, Jakob, Marsh, Judith, Dreger, Peter, and Dufour, Carlo

Subjects
Oncology, medicine.medical_specialty, lymphoid neoplasms, Bone marrow transplantation, business.industry, lymphoid neoplasm, haematopoietic stem cell transplantation, lymphoma, Hematology, medicine.disease, aplastic anaemia, Lymphoma, Settore MED/01 - Statistica Medica, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Lymphoid neoplasms, 610 Medicine & health, business, 030215 immunology
Published
2019

Catalog

Books, media, physical & digital resources
See catalog results